250 related articles for article (PubMed ID: 26060225)
1. Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.
Ramsey SD; Fedorenko C; Chauhan R; McGee R; Lyman GH; Kreizenbeck K; Bansal A
J Oncol Pract; 2015 Jul; 11(4):338-43. PubMed ID: 26060225
[TBL] [Abstract][Full Text] [Related]
2. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
3. Do Wise Choices Translate Into Cost Savings and Improved Outcomes?
Blayney DW
J Oncol Pract; 2015 Jul; 11(4):344-5. PubMed ID: 26060226
[No Abstract] [Full Text] [Related]
4. Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
Henry NL; Braun TM; Breslin TM; Gorski DH; Silver SM; Griggs JJ
Cancer; 2017 Aug; 123(15):2975-2983. PubMed ID: 28301680
[TBL] [Abstract][Full Text] [Related]
5. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
6. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
[TBL] [Abstract][Full Text] [Related]
7. Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?
Simos D; Hutton B; Clemons M
J Oncol Pract; 2015 Jan; 11(1):62-8. PubMed ID: 25392522
[TBL] [Abstract][Full Text] [Related]
8. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative.
Miles RC; Lee CI; Sun Q; Bansal A; Lyman GH; Specht JM; Fedorenko CR; Greenwood-Hickman MA; Ramsey SD; Lee JM
J Natl Compr Canc Netw; 2019 Jul; 17(7):813-820. PubMed ID: 31319393
[TBL] [Abstract][Full Text] [Related]
10. High-cost imaging in elderly patients with stage IV cancer.
Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with imaging in patients with early breast cancer after initial treatment.
Enright K; Desai T; Sutradhar R; Gonzalez A; Powis M; Taback N; Booth CM; Trudeau ME; Krzyzanowska MK
Curr Oncol; 2018 Apr; 25(2):126-132. PubMed ID: 29719428
[TBL] [Abstract][Full Text] [Related]
12. The Impact of the Choosing Wisely Campaign in Urology.
Welk B; Winick-Ng J; McClure JA; Lorenzo AJ; Kulkarni G; Ordon M
Urology; 2018 Jun; 116():81-86. PubMed ID: 29572056
[TBL] [Abstract][Full Text] [Related]
13. Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.
Makarov DV; Soulos PR; Gold HT; Yu JB; Sen S; Ross JS; Gross CP
JAMA Oncol; 2015 May; 1(2):185-94. PubMed ID: 26181021
[TBL] [Abstract][Full Text] [Related]
14. Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.
Hahn EE; Tang T; Lee JS; Munoz-Plaza C; Adesina JO; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
J Oncol Pract; 2015 May; 11(3):e320-8. PubMed ID: 25901056
[TBL] [Abstract][Full Text] [Related]
15. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
16. Choosing Wisely in Oncology: Are We Ready For Value-Based Care?
Rocque G; Blayney DW; Jahanzeb M; Knape A; Markham MJ; Pham T; Shelton J; Sudheendra P; Evans T
J Oncol Pract; 2017 Nov; 13(11):e935-e943. PubMed ID: 28783425
[TBL] [Abstract][Full Text] [Related]
17. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.
Baltz AP; Siegel ER; Kamal AH; Siegel R; Kozlik MM; Crist STS; Makhoul I;
JCO Oncol Pract; 2023 Feb; 19(2):e274-e285. PubMed ID: 36375114
[TBL] [Abstract][Full Text] [Related]
19. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
[No Abstract] [Full Text] [Related]
20. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
